 |
 |
 |
 |
|
| 21. |
Woodhall et al. Estimation of the impact of genital warts on health-related quality of life. Sex. Transm. Inf. 2008; 84:161-166 |
| 22. |
Brown D. First analysis of cross-protection against persistent infection cervical intraepithelial neoplasia & adenocarcinoma in situ caused by oncogenic HPV types in addition to 16/18. Presented on September 2007 at ICAAC, Chicago |
| 23. |
Luna J, Saah A, Hood S, et al. The FUTURE III trial. 24TH INTERNATIONAL PAPILLOMAVIRUS CONFERENCE & CLINICAL WORKSHOP, NOV 3-9, 2007, BEIJING, CHINA. Nov, 2007: PA1-04. |
| 24. |
Bonnez W. Papillomavirus. In: Richman DD, Whitley RJ, Hayden FG, eds. Clinical Virology. New York, NY; Churchill Livingstone;2002:569-611 |
| 25. |
Hong Kong Department of Health. Cervical Screening Programme. Cervical Cancer, Symptoms. Available at:
http://www.cervicalscreening.gov.hk/english/cc/cc_symptoms.html |
|
 |
|
